Today, CLEAR, the secure identity company, and Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced a new collaboration that aims to foster safer public environments and help reduce public health risk.
NEW YORK and SECAUCUS, N.J., Oct. 5, 2020 /PRNewswire/ -- Today, CLEAR, the secure identity company, and Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced a new collaboration that aims to foster safer public environments and help reduce public health risk. This collaboration brings together CLEAR’s safe and secure “Health Pass” technology with Quest’s advanced COVID-19 testing capabilities. Health Pass is a new mobile app product by CLEAR which securely connects a person’s verified identity to multiple layers of COVID-19 related insights to reduce public health risk and give organizations the insights to help foster confidence for employees and consumers. CLEAR Health Pass connects mobile identity verification technology with real-time health surveys, data from temperature checks, and now, verified Quest Diagnostics COVID-19 test results. The collaboration is significant for providing a combined touchless-COVID-19 screening solution on a national scale. Quest Diagnostics is at the forefront of pandemic response in the United States, providing more than 16 million COVID-19 molecular diagnostic tests nationally since early March, more than any other single lab provider. CLEAR’s Health Pass is being used by partners across industries, including the National Hockey League’s Stanley Cup Playoffs, the 9/11 Memorial & Museum, Danny Meyer’s Union Square Hospitality Group, Chop’t and Dos Toros restaurants, and the Seattle Seahawks. “At CLEAR, we are committed to helping people return to their daily lives more safely and securely, and linking Health Pass with laboratory data from industry leader Quest Diagnostics is a key step forward towards that objective,” said CLEAR CEO Caryn Seidman-Becker. “We are proud to give partners the tools they need to make reopening as safe as possible for their employees, customers, and community.” “As individuals consider ways to travel, work and engage with others more safely, they increasingly rely on data to help make informed decisions,” said Cathy Doherty, Senior Vice President and Group Executive – Clinical Franchise Solutions and Marketing for Quest Diagnostics. “Our collaboration with CLEAR brings together advanced science and technology to transform COVID-19 test results into insights that inform decisions to help improve health and safety.” Under the collaboration, individuals who receive testing for COVID-19 from Quest Diagnostics can opt to download the Quest Diagnostics mobile app and patient portal, MyQuest. MyQuest is a free and secure tool with more than 11 million subscribers that makes it easy to get test results, schedule appointments, track health history, and more, all in one place. To leverage the combined offering, eligible Health Pass users must first provide consent and authorization, then they simply log in to their MyQuest patient portal through the CLEAR app, to link their accounts. Health Pass only communicates a comprehensive red or green signal to employers and venues — never providing access to a user’s personal health details. How It Works: Health Pass Makes it Easy to Create Safer Environments Enroll, Verify and You Are Good to Go.
About Clear About COVID-19 Testing by Quest Diagnostics About Quest Diagnostics View original content to download multimedia:http://www.prnewswire.com/news-releases/clear-and-quest-diagnostics-collaborate-to-integrate-covid-19-test-results-with-health-pass-for-safer-environments-301145910.html SOURCE Quest Diagnostics | ||
Company Codes: NYSE:DGX |